Table 1.
Demographic details of participants and prevalence of health consequences relating to vaccination.
| Characteristics | No of participants | Total no. of participants | Percentage | |
|---|---|---|---|---|
| Male | 118 | 258 | 45.7% | |
| Female | 140 | 54.3% | ||
| Age group | Under 20 years | 108 | 258 | 41.9% |
| 21–30 years | 119 | 46.1% | ||
| 31–40 years | 18 | 7% | ||
| 41–50 years | 6 | 2.3% | ||
| 51–60 years | 2 | 0.8% | ||
| Older than 60 | 5 | 1.9% | ||
| Habits | Alcohol | 16 | 258 | 6.2% |
| Smoking | 11 | 4.3% | ||
| Chewing tobacco | 1 | 0.4% | ||
| Occupation | UG and PG students | 174 | 258 | 67.4% |
| Lecturer | 19 | 7.4% | ||
| Pharmacist | 15 | 5.8% | ||
| Doctors | 15 | 5.8% | ||
| Nurses | 7 | 2.7% | ||
| Researcher | 8 | 3.1% | ||
| Other workers | 20 | 7.8% | ||
| Vaccine | AZD1222® | 228 | 258 | 88.4% |
| BBV152® | 30 | 11.6% | ||
| Post-vaccination reaction | Within 3 days | 191 | 258 | 74.1% |
| Beyond 3 days | 19 | 7.3% | ||
| Male (n = 118) | 77 (65.25%) | 29.8% | ||
| Female (n = 140) | 114 (81.42%) | 44.19% | ||
| Post-vaccination medicine used. | 152 | 258 | 58.9% | |
| Post-vaccination leave taken | 79 | 30.6% | ||
| Cold & cough | Recently suffer from | 79 | 258 | 30.6% |
| Believing increase in frequency (n = 79) | 34 (43.03%) | 13.18% | ||
| Required longer recovery time (n = 79) | 29 (32.9%) | 11.24% | ||
| Post-vaccination prevalence of health issues | Total | 93 | 258 | 36.05% |
| Male (n = 118) | 40 (33.9%) | 15.5% | ||
| Female (n = 140) | 53 (37.86%) | 20.54% | ||
| Health issues prevalence as a respect to duration | 30–89 days (n = 129) | 46 (35.66%) | 93 | 49.46% |
| 90–179 days (n = 80) | 30 (37.5%) | 32.26% | ||
| More than 180 days (n = 49) | 17 (34.69%) | 18.27% | ||